Abstract
In industrialized countries, overweight and obesity account for approximately 13.8% and 24.9% of the kidney disease observed in men and women, respectively. Moreover, obesity-associated glomerulopathy is now considered as "an emerging epidemic." Kidney function can be negatively impacted by obesity through several mechanisms, either direct or indirect. While it is well established that obesity represents the leading risk factor for type 2 diabetes and hypertension, awareness that obesity is associated with direct kidney damage independently of hypertension and diabetes is still not widespread. In this paper we will discuss the emerging role of adipose tissue, particularly in the visceral depot, in obesity-induced chronic kidney damage.
| Original language | English |
|---|---|
| Pages (from-to) | 354-363 |
| Number of pages | 10 |
| Journal | International Journal of Immunopathology and Pharmacology |
| Volume | 29 |
| DOIs | |
| Publication status | Published - 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Immunology
- Immunology and Allergy
- Pharmacology
- hyperfiltration
- kidney disease
- obesity
Fingerprint
Dive into the research topics of 'Obesity and kidney disease: Beyond the hyperfiltration'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver